Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 155.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.452%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Jan 2019 07:00

RNS Number : 3310O
Crimson Tide PLC
29 January 2019
 

 

Crimson Tide plc ("Crimson Tide" or "the Company")

Trading Update for the year ended 31 December 2018

 

PROFITS EXPECTED TO BE AHEAD OF MARKET EXPECTATIONS

EXCITING DEVELOPMENTS ACROSS THE BUSINESS

 

· Profit before tax expected to be ahead of market forecast

· Customers generating long-term revenues up 18%

· Record opportunities generated in 2018 up over 250%

· New IoT solution sales channel created

· Maiden NHS order taken with 2019 growth expected

· International expansion with first customers in Denmark and Dubai

· Growing partner community contributing early revenues

· Successful pilot in Tanzania and Indonesia with a Global Regulatory Authority in pharmaceuticals

· Biometric Time & Attendance module released to market with early adoption in evidence

· New web client released in Q4 2018 well received by customers and prospects

· mpro5 platform in use in over 250,000 sites

 

Crimson Tide, the creator of mpro5 - a leading cloud-based managed mobility service (AIM: TIDE.L), announces a trading update for the year ended 31 December 2018. The Company is pleased to announce that it expects Profit Before Tax to be ahead of market forecasts, subject to year-end financial close and audit procedures.

This is especially pleasing notwithstanding the substantial investments in new sales & marketing staff and associated expenditure in line with the strategy communicated to the market. Revenues continued to grow which was particularly pleasing given the Company's continued strategy to convert consultancy and hardware sales revenue to long term subscription revenue. At the year end the Company had cash at bank in excess of £600k and had reduced the debt on device lease agreements resulting in another increase at the year end in Net Funds.

Following the Company's investments in sales & marketing during 2018, Crimson Tide saw an accelerated number of subscriber additions, ending the period with an increase in the customer base of 18%, all of which will contribute to long-term subscription revenues. The platform is now in use in over 250,000 sites. The Company has also experienced a sharp rise in the number of opportunities generated during the year, and at the period end recorded an increase of over 250% in the number of opportunities.

Investment in the mpro5 platform in 2018 brought a new Internet of Things (IoT) module, '5things' to its existing customer base. This module moves the mpro5 platform into the automation space, allowing real-time monitoring via sensors and automated scheduling to mobile devices. This module allows for new opportunities for upselling to the entire existing subscription base.

To compliment this offering, the Company has invested in a new 'Solution Sales' channel being launched in January 2019, offering IoT, MDM (Mobile Device Management), and SIM connections to existing and new customers alike. The Company is also pleased to announce the recruitment of a new Director of Solution Sales for this channel, directly from the UK's largest independent business telecommunications provider, having over 30 years' experience in the field.

The Company's mpro5 platform was successfully certified and listed on the Government's G-Cloud Marketplace in 2018. This allows for hundreds of public sector organisations to independently research and purchase mpro5 subscription services directly, and the Company was pleased to announce its first subscription with an NHS trust as of March 2018 and is focused on extending this to cover further trusts in 2019.

Subscriber additions were made internationally and the Company welcomed its first subscribers in both Dubai and Denmark. Both markets are using the mpro5 service in the well-established verticals of facilities management and cleaning.

The Company has received positive feedback from two pilots running in the pharmaceuticals industry in Tanzania and the Philippines respectively, whereby its mpro5 platform is being used to capture, collate, and notify in real-time a global regulatory authority of counterfeit pharmaceuticals in the supply chain. The Company is hopeful of wider adoption globally.

Crimson Tide has established a partner channel which added revenue in late 2018 within the market of transport & logistics. The Company is optimistic in pursuing these new markets with its mpro5 offering. This channel is expected to deliver further growth opportunities from 2019.

Development of the mpro5 platform includes a new biometric Time & Attendance module, allowing customers to monitor attendance of staff on disparate locations using facial recognition, fingerprint, or landline PIN authentication. Customer adoption is already in evidence.

In late Q4 the Company completed the development of its new web client 'Project13.' This has been released to the entire customer base as of Jan 2019 to widespread positive feedback.

 

Barrie Whipp, Executive Chairman of Crimson Tide, commented:

"We can take great encouragement from 2018. Our investments in Sales & Marketing have begun to pay off. Enhancements in mpro5 and the widening of our channels mean that the Board is very optimistic for the future."

 

Luke Jeffrey, Chief Executive Officer of Crimson Tide, commented:

"2018 has been an incredible year of transformation for the Company and our mpro5 platform. We are readily positioned with the right product to prosecute our successful marketing strategy.

The huge growth in opportunity indicates appetite for our SaaS offering, and the long-term subscription gives us great future visibility of revenues.

Our first partners are excited about the programme and our international expansion is really starting to pick up pace.

I am incredibly proud of our team and the service that we continue to deliver to our subscribers."

 

Enquiries:

Crimson Tide plc 01892 542444 

Barrie Whipp / Luke Jeffrey

Arden Partners 020 7614 5900

Steve Douglas / John Llewellyn-Lloyd / Dan Gee-Summons

 

For further information on Crimson Tide plc, see the website at: www.crimsontide.co.uk/

The information contained within this RNS is considered to be inside information prior to its release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBPMPTMBBTBFL
Date   Source Headline
17th Apr 202410:05 amRNSBoard Changes
17th Apr 20247:00 amRNSPreliminary Results to 31 December 2023
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.